Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Older Patients
- 1 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medicine
- Vol. 87 (4), 203-209
- https://doi.org/10.1097/md.0b013e31817c744b
Abstract
Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is increasingly recognized in older patients. The differences in disease presentation and outcome between older and younger patients remain controversial. We conducted the current study to analyze the characteristics of patients aged over 65 years with AAV and to compare the younger and older cohorts. We recruited 234 consecutive Chinese patients with AAV. We compared clinical and pathologic characteristics as well as outcomes between younger and older patients. Among the 234 patients with AAV, 99 were older than 65 years. Compared with the 135 younger patients, the older patients had a significantly higher proportion of positive myeloperoxidase-ANCA (94.9% vs. 80.0%, p < 0.01) and a higher proportion of microscopic polyangiitis (79.8% vs. 50.4%, χ2 = 11.8, p < 0.001), but had a lower proportion of Wegener granulomatosis (18.2% vs. 37.8%, p < 0.01) and renal-limited vasculitis (0% vs. 11.1%, p < 0.001). Older patients had more prevalent and severe pulmonary involvement than younger patients, including pulmonary infiltration, interstitial fibrosis, and mechanical ventilation dependence at presentation (47.5% vs. 31.9%, p < 0.05; 37.4% vs. 18.5%, p < 0.01; and 9.1% vs. 1.5%, p < 0.05, respectively). Older patients were less likely to respond to treatment (p < 0.01) and had worse survival than younger patients (p = 0.000). During follow-up, older patients had a higher risk of secondary pulmonary infection (p < 0.001), and those with pulmonary interstitial fibrosis were more likely to develop secondary pulmonary infections (p < 0.05). In conclusion, compared with younger patients, older patients with AAV had more severe and more prevalent pulmonary lesions, which might contribute to subsequent pulmonary infections after the initiation of immunosuppressive therapy. Age and pulmonary infection were independent predictors of death.Keywords
This publication has 14 references indexed in Scilit:
- EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisAnnals Of The Rheumatic Diseases, 2007
- Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2006
- Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centrePostgraduate Medical Journal, 2005
- Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitisArthritis & Rheumatism, 2005
- ANCA-associated renal vasculitis at the end of the twentieth century—a disease of older patientsRheumatology, 2004
- Outcome of ANCA-associated renal vasculitis: a 5-year retrospective studyAmerican Journal of Kidney Diseases, 2003
- Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroupsKidney International, 2002
- Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritisKidney International, 1999
- The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreementNephrology Dialysis Transplantation, 1996
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994